Development and clinical feasibility testing of the Pain Treatment Planning Questionnaire
08 cze 2020
O artykule
Kategoria artykułu: Clinical Practice
Data publikacji: 08 cze 2020
Zakres stron: 12 - 24
DOI: https://doi.org/10.17225/jhp00155
Słowa kluczowe
© 2020 Susan M Tupper et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1

Figure 2


Participants reporting activity limitations or mood interference within CPGS clusters
Activity limitations from pain | No | 23 | 2 | p=0.081 |
Yes | 10 | 5 | ||
Mood interference from pain | No | 21 | 1 | p=0.041 |
Yes | 14 | 6 |
Pain characteristics identified on PTPQ (sample n=42 unless otherwise specified)
Current pain (0–10) | 2.3 (2.0) |
Lowest pain in past 30 days (0–10) | 1.5 (1.8) |
Worst pain in past 30 days (0–10) | 5.3 (2.8) |
Usual pain in past 30 days (0–10) | 2.4 (2.0) |
Number of pain descriptive words | 3.9 (3.1) |
Pain typically worse during certain time of day (% “yes”) n=41 | 53.7 % |
Pain interference with activities (% “yes”) n=40 | 37.5 % |
Pain interference with mood (% “yes”) | 47.6 % |
Use pharmaceutical treatments (% selecting at least one treatment) | 85.7 % |
Use psychological treatments (% selecting at least one treatment) | 47.6 % |
Use preventative treatments (% selecting at least one treatment) | 69.0 % |
Use physical treatments (% selecting at least one treatment) | 69.0 % |
Achieve recommended weekly exercise levels (% of total reporting 150+ minutes/week of any cardiovascular exercise) | 19.0 % |
Clinical feasibility study participant characteristics (n=42)
Male | 26 (61.9) |
Female | 16 (38.1) |
VWD | 18 (42.9) |
Haemophilia A | 17 (40.5) |
Haemophilia B | 7 (16.7) |
Grade 0 = Pain Free | 1 (2.4) |
Grade 1 = Low disability, low intensity | 27 (64.3) |
Grade 2 = Low disability, high intensity | 7 (16.7) |
Grade 3 = High disability, moderately limiting | 3 (7.1) |
Grade 4 = High disability, severely limiting | 4 (9.5) |